Summary of Clinically Documented or Presumed Infections
| . | Arm A (375 mg/m2) . | Arm B (500 mg/m2) . | ||
|---|---|---|---|---|
| All Episodes . | Related Episodes . | All Episodes . | Related Episodes . | |
| Patients with infection | 11 (39%) | 5 (18%) | 8 (31%) | 5 (19%) |
| Infection episodes | 14 | 5 | 13 | 5 |
| Bacterial | 8 | 2 | 8 | 4 |
| Viral | 2 | — | 1 | — |
| Fungal | 1 | — | — | — |
| Unknown | 3 | 3 | 4 | 1 |
| Severity of infectious episodes | ||||
| Grade 1 and 2 | 12 | 4 | 12 | 4 |
| Grade 3 and 4 | — | — | — | — |
| Unknown | 2 | 1 | 1 | 1 |
| . | Arm A (375 mg/m2) . | Arm B (500 mg/m2) . | ||
|---|---|---|---|---|
| All Episodes . | Related Episodes . | All Episodes . | Related Episodes . | |
| Patients with infection | 11 (39%) | 5 (18%) | 8 (31%) | 5 (19%) |
| Infection episodes | 14 | 5 | 13 | 5 |
| Bacterial | 8 | 2 | 8 | 4 |
| Viral | 2 | — | 1 | — |
| Fungal | 1 | — | — | — |
| Unknown | 3 | 3 | 4 | 1 |
| Severity of infectious episodes | ||||
| Grade 1 and 2 | 12 | 4 | 12 | 4 |
| Grade 3 and 4 | — | — | — | — |
| Unknown | 2 | 1 | 1 | 1 |